Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal

ERR5646987 E-MTAB-10314:SO1_S45_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362487 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646988 E-MTAB-10314:SO2_S46_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362488 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646989 E-MTAB-10314:SO3_S47_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362489 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646990 E-MTAB-10314:SO4_S48_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362490 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646991 E-MTAB-10314:SO5_S49_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362491 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646992 E-MTAB-10314:SO6_S50_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362492 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646993 E-MTAB-10314:SO1_S61_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362493 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646994 E-MTAB-10314:SO2_S62_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362494 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646995 E-MTAB-10314:SO7_S51_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362495 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646996 E-MTAB-10314:SO8_S52_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362496 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646997 E-MTAB-10314:SO9_S53_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362497 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26 ERR5646998 E-MTAB-10314:SO10_S54_R Illumina HiSeq 4000 paired end sequencing; ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib for 35 days followed by drug withdrawal ERX5362498 ENA-FIRST-PUBLIC 2022-09-26 ENA-LAST-UPDATE 2022-09-26